Satellos Announces Pricing of US$50 Million Public Offering in Canada and the United States
Satellos Bioscience Inc. (TSX: MSCL, Nasdaq: MSLE) (Satellos or the Company), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, today...